Amarin Corp Plc (AMRN)

[ziploc_1]

CBB...I agree..."Where you could end up being right is if a combo drug
were developed as a "one a day" product."

A once a day enhanced Vascepa could could undergo lab studies for it's content of EPA and then be submitted to the to the U.S. FDA for approval...A once a day product has already been studied by Mochida in Japan and submitted to their regulatory authorities about a year ago.

After approval,the once a day Vascepa it could promptly be marketed in a blister pack with a fixed dose of a statin.

I assume that work on combining a fixed dose of a statin within a gelatin capsule is already underway.

This research is being/could be done by Amarin...or, even better, by a BP, owning Amarin, which would have more research, financial, and marketing abilities available....Work on other fixed dose combos of a statin with Vascepa could begin later.

This might seem like a huge project, but there would be a huge market for it.